Your browser doesn't support javascript.
loading
Nonmyeloablative allogeneic transplantation with or without 90yttrium ibritumomab tiuxetan is potentially curative for relapsed follicular lymphoma: 12-year results.
Khouri, Issa F; Saliba, Rima M; Erwin, William D; Samuels, Barry I; Korbling, Martin; Medeiros, L Jeffrey; Valverde, Rosamar; Alousi, Amin M; Anderlini, Paolo; Bashir, Qaiser; Ciurea, Stefan; Gulbis, Alison M; de Lima, Marcos; Hosing, Chitra; Kebriaei, Partow; Popat, Uday R; Fowler, Nathan; Neelapu, Sattva S; Samaniego, Felipe; Champlin, Richard E; Macapinlac, Homer A.
Affiliation
  • Khouri IF; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. ikhouri@mdanderson.org
Blood ; 119(26): 6373-8, 2012 Jun 28.
Article in En | MEDLINE | ID: mdl-22586182
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Follicular / Hematopoietic Stem Cell Transplantation / Transplantation Conditioning / Antibodies, Monoclonal Type of study: Observational_studies / Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Blood Year: 2012 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Follicular / Hematopoietic Stem Cell Transplantation / Transplantation Conditioning / Antibodies, Monoclonal Type of study: Observational_studies / Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Blood Year: 2012 Type: Article Affiliation country: United States